术前选择性经肝动脉化疗栓塞对肝癌患者手术治疗效果的影响

目的：探讨术前选择性经肝动脉化疗栓塞对肝癌患手术治疗效果的影响。方法：回顾性分析126例肝癌患资料，术前选择性经肝动脉化疗栓塞（TACE组）62例，术前未行经肝动脉化疗栓塞（对照组）64例，比两组术后病理检查结果，术后1、2、3年复发率及生存率变化，评价可切除肝癌术前选择性经肝动脉栓塞的作用。结果：术后病理报告TACE组有13例肿瘤完全坏死，对照组则无1例、第1、3年复发率两组无差异，第2年复发率TACE组为29．8％、对照组为58．3％，TACE组明显低于对照组（P＜0．05）。术后1、2年生存率两组无差异，3年生存率TACE为54．4％，对照组为33．3％，TACE组明显于对照组（P＜0．05）。结论：可切除肝癌术前严格掌握条件选择性TACE可在一定程度上提高手术治疗的效果。

Influence of preoperative transcatheter arterial chemoembolization on survival rate for resectable hepatocellular carcinoma

Objective: To study the influence of preoperative transcatheter arterial chemoembolization (TACE) by selection on survival rate of resectable hepatocellular carcinoma (HCC) patients. Methods: Jan. 1996 to Jan. 1997, TACE was performed before surgery in 62 of 126 patients undergoing resection and the other 64 patients without TACE from. Results were retrospectively analyzed with regard to the changes of pathological examination after operation, recurrence rate and survival rate 1, 2, 3 years after operation. Results: Pathological examination showed that there were 13 total necrosis in TACE group, but no one in contrast group. There were no significant difference of recurrence rate 1, 3 years after operation between 2 groups. Recurrence rate 2 years after operation was 29.8% in TACE group, but 58.3% in contrast group. There were significant difference of recurrence rate 2 years after operation between 2 groups ( P <0.05). Survival rate 3 years after operation was 54.4% in TACE group, but 33.3% in contrast group. Survival rate of TACE group was higher than that of contrast group ( P <0.05). There were not significant difference of recurrence rate 1, 2 years after operation between 2 groups. Conclusion: Proper preoperative TACE for resectable HCC can improve the outcome of the operation to some extent.